SPAC

News

Veraxa says delayed US listing is back on track

Swiss biotech Veraxa's listing on the Nasdaq, delayed by the record 43-day US government shutdown, should now complete in the first quarter of 2026.

News

Swiss biotech Veraxa vaults to Nasdaq listing with SPAC deal

Cancer drug developer Veraxa Biotech has reached a deal to merge with a SPAC in a deal that will give it a Nasdaq listing and a $1.6bn-plus valuation.

News

Ex-Sanofi CEO backs first European biomanufacturing SPAC

A new "black cheque" company that claims to be the first in Europe devoted to biomanufacturing has been set up by a team of investors, including former Sanofi chief executive Gerard le Fur.

News

Doctor using mobile smart phone, work on laptop computer with notebook and medical stethoscope on the desk at office. Telehealth, telemedicine or medic tech concept.

Digital health funding boom continues as ETAO cuts SPAC deal

Chinese digital health firm ETAO International will go public via a merger with a blank cheque company that will value it at around $2.5 billion.

News

Health gaming firm Akili takes blank cheque route to public ...

Akili Interactive has agreed a merger with special purpose acquisition company (SPAC) Social Capital Suvretta Holdings Corp I in a deal that will take it into public hands with a valuation

News

Digital health firm Pear goes public, raising $175 million

Pear Therapeutics has completed its merger with blank cheque company Thimble Point Acquisition Corp, claiming a Nasdaq listing and raising $175 million in gross proceeds for the digital hea

Veraxa says delayed US listing is back on track

Swiss biotech Veraxa vaults to Nasdaq listing with SPAC deal

Ex-Sanofi CEO backs first European biomanufacturing SPAC

Digital health funding boom continues as ETAO cuts SPAC deal

Health gaming firm Akili takes blank cheque route to public ...

Digital health firm Pear goes public, raising $175 million

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

SPAC

Editor's Picks